- As China Slows Down, the Philippines Moves to Grab Foreign Investment
- Why Obamacare Subsidies Should Be Struck Down by the Supreme Court
- MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
- Shale Oil Bust Enters Phase Two, Led by Hercules and SandRidge
- Comcast Wants Congress to Gut the New Net Neutrality Rules
March madness has nothing on Wall Street as the first Monday in the month kicks off with several multi-billion dollar deals.
Shareholder activists are mounting campaigns at a record pace, and few are more successful and feared than these ten.
Hospital operator HCA Holdings is on the hunt for more hospitals, especially large ones, often not-for-profits.
Engaged Capital's Glenn Wellington envisions sponsors assisting in campaigns, but bemoans 'white knight' situations.
Nelson Peltz will relinquish his seat at Legg Mason after placing a lieutenant on the New York lender's expanded board.
Ad-tech company Datalogix may be getting attention from potential acquirers, sources tell The Deal's Jonathan Marino.
For retailers, especially those that are already struggling, the holidays can be a real make-or-break time. And that's the situation that teen retailer Wet Seal finds itself in.
It's a field day for activists. Over at animal healthcare company Zoetis, Pershing Square Capital Management's Bill Ackman revealed an 8.5% stake.
Up to now, companies in highly regulated industries were safe from activists.
Madison Square Garden is considering the possibility of splitting into two companies: one to house its sports and media businesses and another its entertainment unit.